For postmenopausal women, more weekly lifting meant bigger metabolic wins

After menopause, women face rising body fat, worsening blood sugar control and creeping low-grade inflammation, all of which feed cardiovascular and metabolic disease risk. Resistance training is increasingly recommended for this group, but how much of it is needed remains far less settled. Volume, usually counted in weekly sets, is one of the easiest levers to adjust in any programme, and it carries a real cost in time and recovery. This review asked whether higher training volumes buy meaningfully better outcomes for adiposity, metabolic risk and inflammation, or whether a smaller dose does the same job.

The authors systematically searched PubMed, Scopus, Web of Science and SciELO for randomised controlled trials in postmenopausal and older women that compared resistance training against a non-training control group. Twenty trials in overweight or obese women were included. Training arms were classed as lower volume, around 44 sets per week, or higher volume, around 77 sets per week. Pooled outcomes covered total and abdominal adiposity, blood lipids, glucose and C-reactive protein, and independent reviewers assessed both the risk of bias and the certainty of the evidence.

Both volume groups improved body adiposity, metabolic risk and inflammation relative to the control groups, so the baseline message is that lifting helped regardless of dose. The separation appeared on two outcomes. For blood glucose and for C-reactive protein, the higher volume groups showed clearly larger effects than the lower volume groups when each was compared with control. The reviewers noted some concerns about risk of bias across the included trials, and rated the overall certainty of the evidence as low to very low, which tempers how firmly the exact sizes should be held.

The result fits the broader dose-response pattern seen across exercise science, and extends it specifically to metabolic and inflammatory outcomes in postmenopausal and older women, a group historically under-represented in training research. It also complicates the popular message that minimal doses are all that matter: minimal doses helped here, but more helped more, at least for blood sugar and inflammation. Where the optimal volume sits, and at what point returns diminish, are questions the included trials cannot answer, and the low certainty ratings mean replication matters.

If you are postmenopausal and lifting partly for metabolic health, this is a reason to see total weekly work as a meaningful dial rather than an afterthought. It is equally a reason not to be discouraged by a modest programme, since lower volumes still beat not training on every pooled outcome. Given the low certainty of the evidence, the sensible reading is direction rather than precise prescription.